Negative signalling for growth and survival in epithelial prostate cells in vivo in benign prostatic hyperplasia (BPH) after tamsulosin

被引:0
|
作者
Carballido, J
Prieto, A
Sanz, M
Vela-Navarrete, R
Korstanje, C
de Mon, MA
机构
来源
JOURNAL OF UROLOGY | 2003年 / 169卷 / 04期
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
1799
引用
收藏
页码:480 / 480
页数:1
相关论文
共 50 条
  • [1] CD38 downregulation on prostate epithelial cells (PEC) is associated with new epithelial growth in benign prostatic hyperplasia (BPH)
    Kramer, G
    Steiner, G
    Sutter, A
    Malavasi, F
    Marberger, M
    JOURNAL OF UROLOGY, 1998, 159 (05): : 113 - 113
  • [2] Population PKS & PDS of tamsulosin, in patients with benign prostatic hyperplasia (BPH)
    Forrest, A
    Collins, DA
    Shore, RM
    Rubino, CM
    Yasukawa, K
    Tajima, Y
    Ito, Y
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PI98 - PI98
  • [3] Effect and safety of tamsulosin, the prostate specific alpha(1)-blocker, in the treatment of BPH (benign prostatic hyperplasia)
    Kawabe, K
    AKTUELLE UROLOGIE, 1996, 27 : 25 - 26
  • [4] Prostate artery embolization (PAE) for benign prostatic hyperplasia (BPH)
    Somani, Bhaskar K.
    Hacking, Nigel
    Bryant, Timothy
    Coyne, John
    Flowers, David
    Harris, Mark
    Dyer, Jonathan
    BJU INTERNATIONAL, 2014, 114 (05) : 639 - 640
  • [5] OUR EXPERIENCE WITH THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH) WITH TAMSULOSIN IN PATIENTS WITH NORMOTENSION OR ORTHOSTATIC HYPOTENSION
    Saidi, S.
    Stankov, O.
    Dohcev, S.
    Stavridis, S.
    Mickovski, A.
    Penev, M.
    Shabani, B.
    Ivanovski, O.
    Popov, Z.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (06) : 598 - 598
  • [7] Prostate development and growth in benign prostatic hyperplasia
    Timms, Barry G.
    Hofkamp, Luke E.
    DIFFERENTIATION, 2011, 82 (4-5) : 173 - 183
  • [8] Prostate stem cells and benign prostatic hyperplasia
    Isaacs, John T.
    PROSTATE, 2008, 68 (09): : 1025 - 1034
  • [9] Photoselective vaporization of the prostate(PVP) for treatment of huge benign prostatic hyperplasia(BPH)
    Jung, Gyung-woo
    Ok, Yunchul
    JOURNAL OF UROLOGY, 2007, 177 (04): : 613 - 614
  • [10] Racial differences in the risk of benign prostatic hyperplasia (BPH) progression and prostate cancer
    Roehrborn, CG
    Logie, JW
    Blackman, N
    Brown, RR
    Lamerato, LE
    Hoke, GP
    JOURNAL OF UROLOGY, 2004, 171 (04): : 408 - 408